Get started
Palatin Technologies, Inc.Palatin Technologies, Inc.Palatin Technologies, Inc.

Palatin Technologies, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

PTN chart


Full chart

PTN upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.64 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.5369 USD
Net income (FY)
‪−29.74 M‬ USD
Revenue (FY)
‪4.49 M‬ USD
Shares float
‪27.33 M‬
Beta (1Y)
0.11

Employees


Employees (FY)
30
Change (1Y)
−4 −11.76%
Revenue / Employee (1Y)
‪149.67 K‬ USD
Net income / Employee (1Y)
‪−991.20 K‬ USD

About Palatin Technologies, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Carl Spana
Website
palatin.com
Headquarters
Cranbury
Founded
1986
FIGI
BBG000BN9PY4
Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Cranbury, NJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PTN news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as PTN.

Frequently Asked Questions


The current price of PTN is 0.1904 USD — it has increased by 15.39% in the past 24 hours. Watch Palatin Technologies, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Palatin Technologies, Inc. stocks are traded under the ticker PTN.
PTN stock has fallen by −63.48% compared to the previous week, the month change is a −74.95% fall, over the last year Palatin Technologies, Inc. has showed a −90.43% decrease.
We've gathered analysts' opinions on Palatin Technologies, Inc. future price: according to them, PTN price has a max estimate of 7.00 USD and a min estimate of 7.00 USD. Watch PTN chart and read a more detailed Palatin Technologies, Inc. stock forecast: see what analysts think of Palatin Technologies, Inc. and suggest that you do with its stocks.
PTN reached its all-time high on Oct 28, 1993 with the price of 100,000.0000 USD, and its all-time low was 0.1605 USD and was reached on Apr 11, 2025. View more price dynamics on PTN chart.
See other stocks reaching their highest and lowest prices.
PTN stock is 30.40% volatile and has beta coefficient of 0.11. Track Palatin Technologies, Inc. stock price on the chart and check out the list of the most volatile stocks — is Palatin Technologies, Inc. there?
Today Palatin Technologies, Inc. has the market capitalization of ‪5.36 M‬, it has decreased by −9.72% over the last week.
Yes, you can track Palatin Technologies, Inc. financials in yearly and quarterly reports right on TradingView.
Palatin Technologies, Inc. is going to release the next earnings report on May 20, 2025. Keep track of upcoming events with our Earnings Calendar.
PTN earnings for the last quarter are −0.12 USD per share, whereas the estimation was −0.42 USD resulting in a 71.43% surprise. The estimated earnings for the next quarter are −0.17 USD per share. See more details about Palatin Technologies, Inc. earnings.
Palatin Technologies, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
PTN net income for the last quarter is ‪−2.44 M‬ USD, while the quarter before that showed ‪−7.82 M‬ USD of net income which accounts for 68.78% change. Track more Palatin Technologies, Inc. financial stats to get the full picture.
No, PTN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has 30 employees. See our rating of the largest employees — is Palatin Technologies, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Palatin Technologies, Inc. EBITDA is ‪−29.72 M‬ USD, and current EBITDA margin is −659.01%. See more stats in Palatin Technologies, Inc. financial statements.
Like other stocks, PTN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Palatin Technologies, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Palatin Technologies, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Palatin Technologies, Inc. stock shows the sell signal. See more of Palatin Technologies, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.